BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9051068)

  • 21. Photofrin
    Baran TM
    Lasers Surg Med; 2018 Jul; 50(5):476-482. PubMed ID: 29214668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
    Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
    Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.
    Wolf P; Fink-Puches R; Cerroni L; Kerl H
    J Am Acad Dermatol; 1994 Oct; 31(4):678-80. PubMed ID: 8089302
    [No Abstract]   [Full Text] [Related]  

  • 24. Hand warts successfully treated with topical 5-aminolevulinic acid and intense pulsed light.
    Kalil CL; Salenave PR; Cignachi S
    Eur J Dermatol; 2008; 18(2):207-8. PubMed ID: 18424398
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.
    Adams K; Rainbow AJ; Wilson BC; Singh G
    J Photochem Photobiol B; 1999 Apr; 49(2-3):136-41. PubMed ID: 10392463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial.
    Eljamel MS; Goodman C; Moseley H
    Lasers Med Sci; 2008 Oct; 23(4):361-7. PubMed ID: 17926079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
    Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
    Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells.
    Chang CJ; Sun CH; Liaw LH; Berns MW; Nelson JS
    Lasers Surg Med; 1999; 24(3):178-86. PubMed ID: 10229148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
    van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
    Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.
    Garland MJ; Cassidy CM; Woolfson D; Donnelly RF
    Future Med Chem; 2009 Jul; 1(4):667-91. PubMed ID: 21426032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of topical 5-aminolevulinic acid-photodynamic therapy with carbon dioxide laser for sebaceous hyperplasia.
    Kim SK; Do JE; Kang HY; Lee ES; Kim YC
    J Am Acad Dermatol; 2007 Mar; 56(3):523-4. PubMed ID: 17317498
    [No Abstract]   [Full Text] [Related]  

  • 33. Photodynamic therapy of photofrin II and excimer dye laser on experimental tumors.
    Tanaka M; Uchibayashi T; Obata T; Sasaki T
    Cancer Lett; 1995 Apr; 90(2):163-9. PubMed ID: 7736452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous low-irradiance photodynamic therapy: a new therapeutic paradigm.
    Rogers GS
    J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S14-7. PubMed ID: 23055207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of photodynamic therapy of Barrett's esophagus.
    Wang KK
    Gastrointest Endosc; 1999 Mar; 49(3 Pt 2):S20-3. PubMed ID: 10049443
    [No Abstract]   [Full Text] [Related]  

  • 36. Shining the light on photodynamic therapy in the treatment of extramammary Paget's disease.
    Cherpelis BS
    Dermatol Surg; 2010 Nov; 36(11):1725. PubMed ID: 20979337
    [No Abstract]   [Full Text] [Related]  

  • 37. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system.
    Hammer-Wilson MJ; Ghahramanlou M; Berns MW
    Lasers Surg Med; 1999; 24(4):276-84. PubMed ID: 10327046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer.
    Abulafi AM; DeJode ML; Allardice JT; Ansell JK; Williams NS
    Br J Surg; 1997 Mar; 84(3):368-71. PubMed ID: 9117310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy: an update.
    Dima VF; Vasiliu V; Dima SV
    Roum Arch Microbiol Immunol; 1998; 57(3-4):207-30. PubMed ID: 11845434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.